相关实验视频

Updated: Jan 8, 2026

Generation of Escape Variants of Neutralizing Influenza Virus Monoclonal Antibodies
07:55

Generation of Escape Variants of Neutralizing Influenza Virus Monoclonal Antibodies

Published on: August 29, 2017

12.2K

从人类B细胞中分离针对SARS-CoV-2的广泛中和单克隆抗体的协议

Xueyan Huang1, Maosheng Lu1, Ling Li2

  • 1Laboratory of Immunoengineering, Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei 230031, China; University of Science and Technology of China, Hefei 230026, China.

STAR protocols
|December 14, 2025
PubMed
概括

这项研究详细介绍了一项协议,用于从人类B细胞中分离针对SARS-CoV-2的广泛中和单克隆抗体 (bnAbs). 这些bnAbs对于开发有效的治疗方法和针对SARS-CoV-2变种和相关病毒的疫苗至关重要.

关键词:
抗体是对抗体的一种.高通量选的高通量选免疫学 免疫学 免疫学微生物学 微生物学分子生物学分子生物学一个单细胞的单细胞.

更多相关视频

Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood13:14

Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood

Published on: February 6, 2018

10.9K
Author Spotlight: Studying Host-Virus Interactions with Pseudotyped Viruses05:49

Author Spotlight: Studying Host-Virus Interactions with Pseudotyped Viruses

Published on: November 21, 2023

2.4K

相关概念视频

Hybridoma Technology01:31

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
17.1K